One of life’s greatest certainties is its uncertainty – that the unexpected, unplanned, and unpredicted may happen and we do the best we can to handle it.
Rachel Sauer
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045
Community Advocacy Palliative care
One of life’s greatest certainties is its uncertainty – that the unexpected, unplanned, and unpredicted may happen and we do the best we can to handle it.
Education Community Students Advocacy CU Medicine Today
The impacts of climate change on human health are among the most profound and far-reaching issues in health care. Global ecosystems are under such stress that the effects of climate change on human health grow more widespread and damaging by the day.
Campus Life Community Students Advocacy
The wind kicked up as soon as everyone “died,” cold and fierce around the dozens of students, faculty members, and staff members lying on the concrete and browning grass.
It began with a three-week plastic-free challenge that changed the course of Bhargavi Chekuri’s medical career path. The challenge was to go three weeks without the ease and convenience of plastic bags, plastic wrapping, and all the other plastics that make their way into daily life.
CPR
July 25, 2024
In Colorado and across the nation, emergency departments at pediatric hospitals are overflowing with kids who need intensive mental health treatment.
9News
July 23, 2024
A little more than a month after the Olympics wrap up, women triathletes will be heading to the south of France for another competition on the global stage.
Healthy Debate
July 18, 2024
In 1961, Yuri Gagarin became the first human in space. With every kilometre he ascended, he pushed the boundaries of human achievement and catalyzed a surge of interest in exploration, research, development – and medical innovation.
Medscape
July 18, 2024
Experts debating the pressing issue of how to prioritize patients in the increasingly common scenario of loss of access or insurance coverage for anti-obesity glucagon-like peptide 1 (GLP-1) receptor agonist drugs argued that comorbidities and obesity severity should strongly warrant continued coverage — while offering key strategies for getting and retaining approval from payers.